Evaluation of Angiotensin Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Renoprotective Response to Angiotensin Receptor Blockers in Iraqi Patients with Diabetic Kidney Disease
Oman Medical Journal · 2026
DOI: 10.5001/omj.2026.69 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oman Medical Journal, 2026. Verfasst von Ansam Abdulameer Yahya und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yahya, A. A., Kadhim, D. J., & Abdalhadi, N. A. (2026). Evaluation of Angiotensin Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Renoprotective Response to Angiotensin Receptor Blockers in Iraqi Patients with Diabetic Kidney Disease. Oman Medical Journal. https://doi.org/10.5001/omj.2026.69
Vancouver
Yahya AA, Kadhim DJ, Abdalhadi NA. Evaluation of Angiotensin Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Renoprotective Response to Angiotensin Receptor Blockers in Iraqi Patients with Diabetic Kidney Disease. Oman Medical Journal. 2026. doi:10.5001/omj.2026.69
BibTeX
@article{Yahya2026,
author = {Yahya, Ansam Abdulameer and Kadhim, Dheyaa Jabbar and Abdalhadi, Nassar Abdalaema},
title = {Evaluation of Angiotensin Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Renoprotective Response to Angiotensin Receptor Blockers in Iraqi Patients with Diabetic Kidney Disease},
journal = {Oman Medical Journal},
year = {2026},
doi = {10.5001/omj.2026.69}
}
EUVIMED